|
Originally published In Press as doi:10.1074/jbc.M212118200 on February 12, 2003
J. Biol. Chem., Vol. 278, Issue 17, 14978-14984, April 25, 2003
Fes Tyrosine Kinase Promotes Survival and Terminal Granulocyte
Differentiation of Factor-dependent Myeloid Progenitors
(32D) and Activates Lineage-specific Transcription Factors*
Jynho
Kim,
Yoshiyasu
Ogata, and
Ricardo
A.
Feldman
From the Department of Microbiology and Immunology, University of
Maryland School of Medicine, Baltimore, Maryland 21201
The c-fps/fes
proto-oncogene encodes a 92-kDa protein-tyrosine kinase that is
involved in myeloid cell development and function. We have recently
shown that expression of an activated allele of Fes
(Fesact) in monocyte precursors resulted in their
differentiation into functional macrophages through the activation of
lineage-specific transcription factors. We now report that this kinase
also plays a role in the survival and terminal differentiation of
granulocyte progenitors. The expression of Fesact in
factor-dependent 32D cells prevented their apoptotic death after interleukin-3 removal, but Fesact-expressing
cells remained factor-dependent for proliferation. Removal
of interleukin-3 from the Fesact-expressing cells was
followed by granulocytic differentiation in the absence of granulocyte
colony-stimulating factor within 4-8 days. The differentiated cells
had distinctive granulocyte morphology and there was up-regulation of
CD11b, Gr-1, and late differentiation markers such as lactoferrin,
suggesting that this kinase induced terminal granulocytic
differentiation. Concomitantly, Fesact down-regulated the
macrophage marker F4/80, suggesting that the biological activity of Fes
was coordinated in a lineage-specific manner. Further analysis showed
that Fesact caused activation of CCAAT/enhancer-binding
protein- and STAT3, two transcription factors that are involved in
granulocyte differentiation. Our results provide evidence that Fes may
be a key component of the granulocyte differentiation machinery, and
suggest a potential mechanism by which this kinase may regulate
granulocyte-specific gene expression.
*
This work was supported by National Institutes of Health
Grant CA55293.The costs of publication of this
article were defrayed in part by the
payment of page charges. The article
must therefore be hereby marked
"advertisement" in
accordance with 18 U.S.C. Section
1734 solely to indicate this fact.
To whom correspondence should be addressed. Tel.: 410-706-4198;
Fax: 410-706-2129; E-mail: rfeldman@umaryland.edu.
Copyright © 2003 by The American Society for Biochemistry and Molecular Biology, Inc.

CiteULike Complore Connotea Del.icio.us Digg Reddit Technorati What's this?
This article has been cited by other articles:

|
 |

|
 |
 
A. Khanna-Gupta, H. Sun, T. Zibello, L. Lozovatsky, P. K. Ghosh, D. C. Link, M. L. McLemore, and N. Berliner
p120 nucleolar-proliferating antigen is a direct target of G-CSF signaling during myeloid differentiation
J. Leukoc. Biol.,
May 1, 2006;
79(5):
1011 - 1021.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
D. Vradii, S. K. Zaidi, J. B. Lian, A. J. van Wijnen, J. L. Stein, and G. S. Stein
Point mutation in AML1 disrupts subnuclear targeting, prevents myeloid differentiation, and effects a transformation-like phenotype
PNAS,
May 17, 2005;
102(20):
7174 - 7179.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. J. Haigh, M. Ema, K. Haigh, M. Gertsenstein, P. Greer, J. Rossant, A. Nagy, and E. F. Wagner
Activated Fps/Fes partially rescues the in vivo developmental potential of Flk1-deficient vascular progenitor cells
Blood,
February 1, 2004;
103(3):
912 - 920.
[Abstract]
[Full Text]
[PDF]
|
 |
|
Copyright © 2003 by the American Society for Biochemistry and Molecular Biology.
|
Advertisement
Advertisement
|